Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genexol-PM in Advanced Pancreatic Cancer
NCT00111904Phase 2Completed
- Sponsor
- Theradex Oncology
- Start
- May 2005
- Primary completion
- Aug 2007
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of paclitaxel polymeric micelle in pancreatic cancer (PC), sponsored by Theradex Oncology. Primary endpoints: Time to Progression, Time to Treatment Failure and 5 more. Started May 2005; status: completed.
02
Drugs
paclitaxel polymeric micelle
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00111904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00111904.